rewirebio.iobenchmarks
Dataset

Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)

Plasma cfDNA ultra-low-pass whole-genome sequencing at 0.1x of 2,004 patients with 17 cancer types and 1,245 non-cancer individuals.

Evaluation results

19 evaluations · 19 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: DELFI features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.932 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DELFI / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'DELFI' / 'Deep Learning', column 'Performance (AUC)'
Configuration: DELFI features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.921 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DELFI / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'DELFI' / 'Random Forest', column 'Performance (AUC)'
Configuration: DELFI features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.935 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

DELFI / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'DELFI' / 'XGBoost', column 'Performance (AUC)'
Configuration: FDI features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.851 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FDI / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FDI' / 'Deep Learning', column 'Performance (AUC)'
Configuration: FDI features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.847 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FDI / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FDI' / 'Random Forest', column 'Performance (AUC)'
Configuration: FDI features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.844 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FDI / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FDI' / 'XGBoost', column 'Performance (AUC)'
Configuration: FRAGMA features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.853 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FRAGMA / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FRAGMA' / 'Deep Learning', column 'Performance (AUC)'
Configuration: FRAGMA features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.838 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FRAGMA / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FRAGMA' / 'Random Forest', column 'Performance (AUC)'
Configuration: FRAGMA features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.849 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

FRAGMA / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'FRAGMA' / 'XGBoost', column 'Performance (AUC)'
Configuration: Fragmentia-AI trained on ULP-WGS (separate instance)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.956 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

cfDNA sequence / Fragmentia-AI on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'cfDNA sequence' / 'Fragmentia-AI', column 'Performance (AUC)'
Configuration: Griffin features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.885 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Griffin / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Griffin' / 'Deep Learning', column 'Performance (AUC)'
Configuration: Griffin features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.881 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Griffin / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Griffin' / 'Random Forest', column 'Performance (AUC)'
Configuration: Griffin features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.886 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Griffin / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Griffin' / 'XGBoost', column 'Performance (AUC)'
Configuration: Nucleosome features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.81 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Nucleosome / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Nucleosome' / 'Deep Learning', column 'Performance (AUC)'
Configuration: Nucleosome features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.793 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Nucleosome / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Nucleosome' / 'Random Forest', column 'Performance (AUC)'
Configuration: Nucleosome features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.801 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Nucleosome / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Nucleosome' / 'XGBoost', column 'Performance (AUC)'
Configuration: Subnucleosome features with Deep Learning (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.636 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Subnucleosome / Deep Learning on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Subnucleosome' / 'Deep Learning', column 'Performance (AUC)'
Configuration: Subnucleosome features with Random Forest (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.674 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Subnucleosome / Random Forest on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Subnucleosome' / 'Random Forest', column 'Performance (AUC)'
Configuration: Subnucleosome features with XGBoost (Fragmentia-AI paper re-implementation)Protocol: Fragmentia-AI paper: ULP-WGS cancer vs non-cancer AUC on a held-out validation set, six feature sets x three classifiers
Dataset: Geneseeq pan-cancer 0.1x ULP-WGS plasma cohort (2,004 cancers, 1,245 non-cancer)
0.676 AUROC (cancer vs non-cancer, held-out ULP-WGS validation set)
unitless · higher

Uncertainty: Not reported by the source

Coverage: Not reported scored / Not reported eligible

Independent external evaluation · Source checked
Methods, coverage and source

Subnucleosome / XGBoost on the ULP-WGS held-out validation set (Fragmentia-AI paper)

ctdnalit-20261011-fragmentia2026-protocol-ulp-wgs-heldout-auc

Aggregation: Not reported

Toward generalizable prediction of cancer signal using a cell-free DNA language model; Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6) · Table S5, row 'Subnucleosome' / 'XGBoost', column 'Performance (AUC)'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

20 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Assay
PCR-free libraries, ultra-low-pass whole-genome sequencing at 0.1x
Context-only references
Toward generalizable prediction of cancer signal using a cell-free DNA language model

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Cell Reports Medicine, published 2026-06-12; Europe PMC full-text JATS XML of PMC13400139
Retrieved: 2026-10-11T21:41:11Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 42a96f1b59e000d55046eeaa86035b19502b803a3d826fb2f791ee597df5fdbd

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Assay
PCR-free libraries, ultra-low-pass whole-genome sequencing at 0.1x
Context-only references
Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6)

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: mmc1.pdf (Document S1) from the Europe PMC supplementary files of PMC13400139
Retrieved: 2026-10-11T21:41:12Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.assay

Source artifact SHA-256: 357004eed301b424867442bb0c27b8ab94cc60e9a39dc4fc31e5728958122d41

Hash scope: artifact_sha256 is the mmc1.pdf member of the zip bundle served by Europe PMC; the bundle's own bytes vary between downloads

Archive member: mmc1.pdf

Inspected artifact

Negatives
1245
Context-only references
Toward generalizable prediction of cancer signal using a cell-free DNA language model

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Cell Reports Medicine, published 2026-06-12; Europe PMC full-text JATS XML of PMC13400139
Retrieved: 2026-10-11T21:41:11Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: 42a96f1b59e000d55046eeaa86035b19502b803a3d826fb2f791ee597df5fdbd

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Negatives
1245
Context-only references
Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6)

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: mmc1.pdf (Document S1) from the Europe PMC supplementary files of PMC13400139
Retrieved: 2026-10-11T21:41:12Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.negatives

Source artifact SHA-256: 357004eed301b424867442bb0c27b8ab94cc60e9a39dc4fc31e5728958122d41

Hash scope: artifact_sha256 is the mmc1.pdf member of the zip bundle served by Europe PMC; the bundle's own bytes vary between downloads

Archive member: mmc1.pdf

Inspected artifact

Population
17 cancer types (breast 97, cervical 80, colorectal 188, oesophageal 95, gastric 128, head and neck 93, kidney 74, liver/cholangiocarcinoma 245, lung 133, melanoma 124, ovarian 242, pancreatic 95, prostate 100, sarcoma 122, thyroid 47, urothelial 78, uterine 63; stages I-IV) and 1,245 non-cancer individuals
Context-only references
Toward generalizable prediction of cancer signal using a cell-free DNA language model

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Cell Reports Medicine, published 2026-06-12; Europe PMC full-text JATS XML of PMC13400139
Retrieved: 2026-10-11T21:41:11Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 42a96f1b59e000d55046eeaa86035b19502b803a3d826fb2f791ee597df5fdbd

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
17 cancer types (breast 97, cervical 80, colorectal 188, oesophageal 95, gastric 128, head and neck 93, kidney 74, liver/cholangiocarcinoma 245, lung 133, melanoma 124, ovarian 242, pancreatic 95, prostate 100, sarcoma 122, thyroid 47, urothelial 78, uterine 63; stages I-IV) and 1,245 non-cancer individuals
Context-only references
Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6)

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: mmc1.pdf (Document S1) from the Europe PMC supplementary files of PMC13400139
Retrieved: 2026-10-11T21:41:12Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 357004eed301b424867442bb0c27b8ab94cc60e9a39dc4fc31e5728958122d41

Hash scope: artifact_sha256 is the mmc1.pdf member of the zip bundle served by Europe PMC; the bundle's own bytes vary between downloads

Archive member: mmc1.pdf

Inspected artifact

Positives
2004
Context-only references
Toward generalizable prediction of cancer signal using a cell-free DNA language model

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Cell Reports Medicine, published 2026-06-12; Europe PMC full-text JATS XML of PMC13400139
Retrieved: 2026-10-11T21:41:11Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: 42a96f1b59e000d55046eeaa86035b19502b803a3d826fb2f791ee597df5fdbd

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Positives
2004
Context-only references
Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6)

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: mmc1.pdf (Document S1) from the Europe PMC supplementary files of PMC13400139
Retrieved: 2026-10-11T21:41:12Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.positives

Source artifact SHA-256: 357004eed301b424867442bb0c27b8ab94cc60e9a39dc4fc31e5728958122d41

Hash scope: artifact_sha256 is the mmc1.pdf member of the zip bundle served by Europe PMC; the bundle's own bytes vary between downloads

Archive member: mmc1.pdf

Inspected artifact

Scope note
Retrospective, multi-centre, sequenced by Nanjing Geneseeq; data access not stated as public.
Context-only references
Toward generalizable prediction of cancer signal using a cell-free DNA language model

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Cell Reports Medicine, published 2026-06-12; Europe PMC full-text JATS XML of PMC13400139
Retrieved: 2026-10-11T21:41:11Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 42a96f1b59e000d55046eeaa86035b19502b803a3d826fb2f791ee597df5fdbd

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Scope note
Retrospective, multi-centre, sequenced by Nanjing Geneseeq; data access not stated as public.
Context-only references
Fragmentia-AI paper, Document S1 (Figures S1-S9 and Tables S1-S6)

Original source ↗

Results P39; STAR Methods P80, P83; Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: mmc1.pdf (Document S1) from the Europe PMC supplementary files of PMC13400139
Retrieved: 2026-10-11T21:41:12Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 357004eed301b424867442bb0c27b8ab94cc60e9a39dc4fc31e5728958122d41

Hash scope: artifact_sha256 is the mmc1.pdf member of the zip bundle served by Europe PMC; the bundle's own bytes vary between downloads

Archive member: mmc1.pdf

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID ctdnalit-20261011-fragmentia2026-data-ulp-wgs.

Source locator: Results P39; STAR Methods P80, P83; Table S4

Related records

Suggest a correction